From sterile filling to final packaging, fill/finish can be one of the most decisive — and difficult — steps on the path to market. Securing the right CDMO partner at this stage can determine timelines, scalability, and long-term success. Outsourced Pharma is here to help you cut through the noise and connect directly with fill/finish experts equipped to move your program forward.
To better reflect our mission, the Outsourced Pharma Capacity Update (OPCU) has evolved into the Outsourced Pharma Capabilities Update. Capacity remains critical, but today’s challenges demand more than open slots. This new identity emphasizes the capabilities, technologies, and specialized fill/finish expertise CDMOs bring to the table, whether you’re managing complex injectables, cold-chain requirements, or late-stage scale-up.
This evolution continues with our ever-expanding PARTNER WEEK, which is organized by capability area, making it easier to identify CDMOs with the specific fill/finish strengths you need at the exact point you need them.
Recent Sessions Available On-Demand
AI Drug Development – 2/17/2026
Upcoming OPCU Topics & Times
Large Molecule | 3/10/2026, AM Session
Fill/Finish | 3/10/2026, PM Session
Small Molecule Drug Substance | 3/11/2026, AM Session
Small Molecule Drug Product | 3/11/2026, PM Session
Cell & Gene | 3/12/2026, AM Session
Analytical Services | 3/12/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
